Corrigendum to “Thiadiazine-thione derivatives ameliorate STZ-induced diabetic neuropathy by regulating insulin and neuroinflammatory signaling” [Int. Immunopharmacol. 113 (2022) 109421] (International Immunopharmacology (2022) 113(PB), (S1567576922009067), (10.1016/j.intimp.2022.109421))
Citations

WEB OF SCIENCE

1
Citations

SCOPUS

2

초록

The authors regret the figures (Figures 4H, 5C,7E) were incorrect in the published version and the corrected figures are provided below.[Formula presented] The authors would like to apologize for any inconvenience caused. © 2024 Elsevier B.V.

제목
Corrigendum to “Thiadiazine-thione derivatives ameliorate STZ-induced diabetic neuropathy by regulating insulin and neuroinflammatory signaling” [Int. Immunopharmacol. 113 (2022) 109421] (International Immunopharmacology (2022) 113(PB), (S1567576922009067), (10.1016/j.intimp.2022.109421))
저자
Qureshi, SoniaAli, GowharMuhammad, TahirIdrees, MuhammadUllah, SultanKhan, Salman AliUllah, RahimKhan, RasoolUl-Haq, ZaheerMohsin, Abdul HaseebKong, Il-Keun
DOI
10.1016/j.intimp.2024.112649
발행일
2024-09-10
유형
Correction
저널명
International Immunopharmacology
138